Shumin Ma

412 total citations
32 papers, 292 citations indexed

About

Shumin Ma is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Shumin Ma has authored 32 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 11 papers in Oncology and 7 papers in Epidemiology. Recurrent topics in Shumin Ma's work include Protein Degradation and Inhibitors (7 papers), Peptidase Inhibition and Analysis (6 papers) and Ubiquitin and proteasome pathways (5 papers). Shumin Ma is often cited by papers focused on Protein Degradation and Inhibitors (7 papers), Peptidase Inhibition and Analysis (6 papers) and Ubiquitin and proteasome pathways (5 papers). Shumin Ma collaborates with scholars based in China, United States and France. Shumin Ma's co-authors include Shijun Chen, Wenjun Du, Junhui Zhen, Zheng‐Xiang Li, Zhixue Liu, Le Zhang, Chong Qin, Siqi Zhang, Zhaomin Zheng and Chenyao Wang and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and The International Journal of Biochemistry & Cell Biology.

In The Last Decade

Shumin Ma

30 papers receiving 289 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shumin Ma China	11	202	70	51	39	28	32	292
Clément Molina France	5	171 0.8×	51 0.7×	107 2.1×	29 0.7×	11 0.4×	6	390
Emmy Chatzigianni Greece	9	177 0.9×	55 0.8×	36 0.7×	50 1.3×	6 0.2×	14	336
Matteus Krappitz Germany	6	135 0.7×	35 0.5×	14 0.3×	90 2.3×	45 1.6×	10	324
Inamul Kabir United States	9	201 1.0×	39 0.6×	93 1.8×	24 0.6×	10 0.4×	12	332
Ekaterina Zezina Germany	10	123 0.6×	51 0.7×	113 2.2×	31 0.8×	6 0.2×	12	309
Zilong Li China	12	193 1.0×	101 1.4×	76 1.5×	41 1.1×	77 2.8×	20	380
Yanhong Bu China	13	249 1.2×	38 0.5×	80 1.6×	57 1.5×	6 0.2×	26	377
Nabora Soledad Reyes de Mochel United States	7	202 1.0×	99 1.4×	109 2.1×	24 0.6×	71 2.5×	7	399
Daniel Fantus United States	6	129 0.6×	37 0.5×	61 1.2×	39 1.0×	6 0.2×	8	301

Countries citing papers authored by Shumin Ma

Since Specialization

Citations

This map shows the geographic impact of Shumin Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shumin Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shumin Ma more than expected).

Fields of papers citing papers by Shumin Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shumin Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shumin Ma. The network helps show where Shumin Ma may publish in the future.

Co-authorship network of co-authors of Shumin Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Shumin Ma. A scholar is included among the top collaborators of Shumin Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shumin Ma. Shumin Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Zixuan, Wenjia Niu, Chengwei Zhang, et al.. (2025). Development and biological evaluation of novel SOS1 inhibitors featuring 5,8-dihydropyrido[4,3-d]pyrimidin-7(6H)-one scaffold. Bioorganic & Medicinal Chemistry Letters. 128. 130344–130344.

Hu, Xiaolin, Shan Gao, Wenrui Jia, et al.. (2025). PSMA-Guided PROTAC Degraders for Tumor-Specific Protein Degradation in Prostate Cancer. Journal of Medicinal Chemistry. 68(10). 10139–10155. 1 indexed citations

Liu, Xiaoyan, et al.. (2024). Hepatocellular carcinoma and AIM2: Therapeutic potential through regulation of autophagy and macrophage polarization. Immunity Inflammation and Disease. 12(9). e70002–e70002. 2 indexed citations

Ma, Shumin, et al.. (2024). Absence of calcium-sensing receptor basal activity due to inter-subunit disulfide bridges. Communications Biology. 7(1). 501–501. 2 indexed citations

Zhang, Chengwei, et al.. (2024). Discovery of a Highly Potent PROTAC Degrader of p300/CBP Proteins for the Treatment of Enzalutamide-Resistant Prostate Cancer. Journal of Medicinal Chemistry. 67(19). 17290–17318. 7 indexed citations

Ma, Shumin, et al.. (2023). Inhibition of Astrocytic Carbohydrate Sulfotransferase 15 Promotes Nerve Repair After Spinal Cord Injury via Mitigation of CSPG Mediated Axonal Inhibition. Cellular and Molecular Neurobiology. 43(6). 2925–2937. 1 indexed citations

Wang, Qiang, Wenkai Zhang, Zhuoyue Li, et al.. (2023). Lethal activity of BRD4 PROTAC degrader QCA570 against bladder cancer cells. Frontiers in Chemistry. 11. 1121724–1121724. 3 indexed citations

Yang, Lele, et al.. (2022). A Gene Transfer-Positive Cell Sorting System Utilizing Membrane-Anchoring Affinity Tag. Frontiers in Bioengineering and Biotechnology. 10. 930966–930966. 2 indexed citations

Liu, Guiqing, et al.. (2022). Serum Extracellular Vesicles Attenuate Cardiomyocyte Injury Induced by Hypoxic/Reoxygenation by Regulating miR-1229-5p. The Tohoku Journal of Experimental Medicine. 258(1). 35–41. 1 indexed citations

10.

Zhang, Wenhua, Xuetao Huang, Shumin Ma, et al.. (2021). The GABA _B receptor mediates neuroprotection by coupling to G ₁₃. Science Signaling. 14(705). eaaz4112–eaaz4112. 11 indexed citations

11.

Liu, Weiqing, et al.. (2021). Discovery of core gene families associated with liver metastasis in colorectal cancer and regulatory roles in tumor cell immune infiltration. Translational Oncology. 14(3). 101011–101011. 9 indexed citations

12.

Liu, Weiqing, et al.. (2021). The association between XRCC3 rs1799794 polymorphism and cancer risk: a meta-analysis of 34 case–control studies. BMC Medical Genomics. 14(1). 117–117. 6 indexed citations

13.

Ma, Shumin, et al.. (2021). rs10514231 Leads to Breast Cancer Predisposition by Altering ATP6AP1L Gene Expression. Cancers. 13(15). 3752–3752. 6 indexed citations

14.

Liu, Weiqing, Jian Dong, Shumin Ma, Lei Liang, & Jun Yang. (2020). A Support Vector Machine Model Predicting the Risk of Duodenal Cancer in Patients with Familial Adenomatous Polyposis at the Transcript Levels. BioMed Research International. 2020(1). 5807295–5807295. 1 indexed citations

15.

Wu, Shiyong, et al.. (2019). An integrated PKD1-dependent signaling network amplifies IRE1 prosurvival signaling. Journal of Biological Chemistry. 294(29). 11119–11130. 4 indexed citations

16.

Su, Qian, Bin Zheng, Wenwen Luo, et al.. (2018). Oxidative Stress Induces Neuronal Apoptosis Through Suppressing Transcription Factor EB Phosphorylation at Ser467. Cellular Physiology and Biochemistry. 46(4). 1536–1554. 21 indexed citations

17.

Liu, Zhixue, Deyi Zhang, Shumin Ma, et al.. (2018). miR-27a is highly expressed in H1650 cancer stem cells and regulates proliferation, migration, and invasion. Journal of Cancer Research and Therapeutics. 14(12). 1004–1004. 12 indexed citations

18.

Luo, Wenwen, Shumin Ma, Chenyao Wang, et al.. (2016). TFEB regulates PER3 expression via glucose-dependent effects on CLOCK/BMAL1. The International Journal of Biochemistry & Cell Biology. 78. 31–42. 11 indexed citations

19.

Du, Wenjun, et al.. (2013). HBV reactivation in an occult HBV infection patient treated with prednisone for nephrotic syndrome: case report and literature review. BMC Infectious Diseases. 13(1). 394–394. 11 indexed citations

20.

Du, Wenjun, Junhui Zhen, Zhaomin Zheng, Shumin Ma, & Shijun Chen. (2013). Expression of AIM2 is high and correlated with inflammation in hepatitis B virus associated glomerulonephritis. Journal of Inflammation. 10(1). 37–37. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact